Virologic Response to Therapy Increases Health-Related Quality of Life for Patients With Chronic Hepatitis B

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 3, 2012, Pages 291-296

  Kim, Jeong Han ^a   Kwon, So Young ^a   Lee, Young Sok ^b   Lee, Joon Hyoek ^c   Lee, Yil Seob ^d   Lee, Chang Hong ^a  

^a Konkuk University School of Medicine   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

^d GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Effects of Treatment; Trial; VAS; Viral Load

Indexed keywords

ADEFOVIR; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CLEVUDINE; ENTECAVIR; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; COMORBIDITY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; LIVER FUNCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; VISUAL ANALOG SCALE;

ADULT; ANTIVIRAL AGENTS; DNA, VIRAL; FEMALE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; REPUBLIC OF KOREA; STATISTICS AS TOPIC; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84857195628     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2011.09.031     Document Type: Article

References (36)

1. Ioannou G.N. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med 2011, 154:319-328.
2. Lok A.S., McMahon B.J. Chronic hepatitis B: update 2009. Hepatology 2009, 50:661-662.
3. Martin L.M., Sheridan M.J., Younossi Z.M. The impact of liver disease on health-related quality of life: a review of the literature. Curr Gastroenterol Rep 2002, 4:79-83.
4. Younossi Z.M., Guyatt G., Kiwi M., et al. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999, 45:295-300.
5. Sun X., Qin W.X., Li Y.P., et al. Comparative cost-effectiveness of antiviral therapies in patients with chronic hepatitis B: a systematic review of economic evidence. J Gastroenterol Hepatol 2007, 22:1369-1377.
6. Levy A.R., Kowdley K.V., Iloeje U., et al. The impact of chronic hepatitis B on quality of life: a multinational study of utilities from infected and uninfected persons. Value Health 2008, 11:527-538.
7. Kim B.K., Kwon S.Y., Lee C.H., et al. [Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea]. Korean J Hepatol 2009, 15:25-41.
8. Foster G.R., Goldin R.D., Thomas H.C. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998, 27:209-212.
9. Bondini S., Kallman J., Dan A., et al. Health-related quality of life in patients with chronic hepatitis B. Liver Int 2007, 27:1119-1125.
10. Mathew A., Peiffer L.P., Rhoades K., et al. Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with pegylated interferon alpha-2b and ribavirin. Health Qual Life Outcomes 2006, 4:30.
11. Tillmann H.L., Wiese M., Braun Y., et al. Quality of life in patients with various liver diseases: patients with HCV show greater mental impairment, while patients with PBC have greater physical impairment. J Viral Hepat 2011, 18:252-261.
12. Pugh R.N., Murray-Lyon I.M., Dawson J.L., et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973, 60:646-649.
13. Brooks R. EuroQol: the current state of play. Health Policy 1996, 37:53-72.
14. EuroQol-a new facility for the measurement of health-related quality of life. Health Policy 1990, 16:199-208. The EuroQol Group.
15. Kim M.H., Cho Y.S., Uhm W.S., et al. Cross-cultural adaptation and validation of the Korean version of the EQ-5D in patients with rheumatic diseases. Qual Life Res 2005, 14:1401-1406.
16. Park S.M., Park M.H., Won J.H., et al. EuroQol and survival prediction in terminal cancer patients: a multicenter prospective study in hospice-palliative care units. Support Care Cancer 2006, 14:329-333.
17. Lee H.Y., Park E.C., Kim H.J., et al. Cost-utility analysis of cochlear implants in Korea using different measures of utility. Acta Otolaryngol 2006, 126:817-823.
18. Choi H.M., Kwon S.Y., Kim Y., et al. Validation of the Korean version of the chronic liver disease questionnaire (CLDQ) for the assessment of health-related quality of life in Korean patients with chronic hepatitis B. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 3rd Asia-Pacific Conference 2008, 87. http://www.ispor.org/awards/3rdAP/PGI3_ISPOR_CLDQ%20validation_final.pdf.
19. Lee Y.R., Kwon S.Y., Lee Y.S., et al. Health state utility assessment by EQ5D in chronic hepatitis B patients in Korea. International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 3rd Asia-Pacific Conference 2008, 63. http://www.ispor.org/awards/3rdAP/KO3_HealthstateutilityassessmentbyEQ5DinKoreanCHBpatients.pdf.
20. Kang E.J., Shin H.S., Park H.J., et al. [A valuation of health status using EQ-5D]. Korean J Health Econ Policy 2006, 12:19-43.
21. Chae H.B., Kim J.H., Kim J.K., et al. Current status of liver diseases in Korea: hepatitis B. Korean J Hepatol 2009, 15(Suppl 6):S13-S24.
22. Kim S., Choi K.H., Hwang S.G., et al. [Validation of the Korean version of liver disease quality of life (LDQOL 1.0) instrument]. Korean J Hepatol 2007, 13:44-50.
23. Younossi Z.M., Boparai N., McCormick M., et al. Assessment of utilities and health-related quality of life in patients with chronic liver disease. Am J Gastroenterol 2001, 96:579-583.
24. Younossi Z.M., Boparai N., Price L.L., et al. Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001, 96:2199-2205.
25. Kopec J.A., Willison K.D. A comparative review of four preference-weighted measures of health-related quality of life. J Clin Epidemiol 2003, 56:317-325.
26. van den Hout W.B., van der Linden Y.M., Steenland E., et al. Single- versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst 2003, 95:222-229.
27. Younossi Z.M., McCormick M., Price L.L., et al. Impact of liver transplantation on health-related quality of life. Liver Transplant 2000, 6:779-783.
28. Fowlie M., Berkeley J. Quality of life-a review of the literature. Fam Pract 1987, 4:226-234.
29. Sobhonslidsuk A., Silpakit C., Kongsakon R., et al. Chronic liver disease questionnaire: translation and validation in Thais. World J Gastroenterol 2004, 10:1954-1957.
30. Rucci P., Taliani G., Cirrincione L., et al. Validity and reliability of the Italian version of the Chronic Liver Disease Questionnaire (CLDQ-I) for the assessment of health-related quality of life. Dig Liver Dis 2005, 37:850-860.
31. Ferrer M., Cordoba J., Garin O., et al. Validity of the Spanish version of the Chronic Liver Disease Questionnaire (CLDQ) as a standard outcome for quality of life assessment. Liver Transplant 2006, 12:95-104.
32. McHutchison J.G., Ware J.E., Bayliss M.S., et al. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 2001, 34:140-147.
33. Bonkovsky H.L., Woolley J.M. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999, 29:264-270.
34. Bernstein D., Kleinman L., Barker C.M., et al. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002, 35:704-708.
35. EASL clinical practice guidelines: management of chronic hepatitis B. J Hepatol 2009, 50:227-242. European Association for the Study of the Liver.
36. Zuberi B.F., Memon A.R., Afsar S., et al. Correlation of quality of life in patients of cirrhosis of liver with etiology and disease severity using disease-specific quality of life questionnaire. J Ayub Med Coll Abbottabad 2007, 19:7-11.